A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4(+) T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256

Background. Despite viral suppression, antiretroviral therapy (ART) does not restore CD4(+) T-cell counts in many patients infected with human immunodeficiency virus type 1 (HIV-1). Methods. In a single-arm pilot trial involving ART recipients with suppressed plasma levels of HIV-1 RNA for at least...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wilkin, Timothy J., Lalama, Christina M., McKinnon, John, Gandhi, Rajesh T., Lin, Nina, Landay, Alan, Ribaudo, Heather, Fox, Lawrence, Currier, Judith S., Mellors, John W., Gulick, Roy, Tenorio, Allan R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2012
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491731/
https://ncbi.nlm.nih.gov/pubmed/22740718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis376
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak